|
1 |
H.629 |
An Act relative to pharmaceutical pricing |
William M. Straus |
|
2 |
H.3551 |
An Act to promote transparency and cost control of pharmaceutical drug prices |
José F. Tosado |
|
3 |
H.79 |
Proposal for a legislative amendment to the Constitution for a constitutional right to health care |
Michael S. Day |
|
4 |
H.1133 |
An Act to ensure prescription drug cost transparency and affordability |
Christine P. Barber |
|
5 |
H.1145 |
An Act relative to the treatment of epilepsy and seizure disorders |
Michael S. Day |
|
6 |
H.1148 |
An Act regarding Massachusetts drug price relief |
William J. Driscoll, Jr. |
|
7 |
H.1154 |
An Act to reduce drug costs through transparency |
Carmine Lawrence Gentile |
|
8 |
H.1162 |
An Act to promote transparency in prescription drug prices |
Kate Hogan |
|
9 |
H.1167 |
An Act relative to prescription drug price transparency |
Bradley H. Jones, Jr. |
|
10 |
H.1168 |
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth |
Bradley H. Jones, Jr. |
|
11 |
H.1178 |
An Act relative to promoting transparency in the pharmaceutical industry |
Ronald Mariano |
|
12 |
H.1193 |
An Act providing for the establishment of a drug cost review commission |
Lindsay N. Sabadosa |
|
13 |
H.1195 |
Resolve providing for an investigation and study by a special commission relative to chronic disease care self-management |
Todd M. Smola |
|
14 |
H.3654 |
An Act relative to compensation for victims of opioids |
James J. O'Day |
|
15 |
S.695 |
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern |
Eric P. Lesser |
|
16 |
S.696 |
An Act to promote transparency and cost control of pharmaceutical drug prices |
Eric P. Lesser |
|
17 |
S.703 |
An Act to define modest meals and refreshments in prescriber education settings |
Jason M. Lewis |
|
18 |
S.706 |
An Act to ensure prescription drug cost transparency and affordability |
Jason M. Lewis |
|
19 |
S.711 |
An Act relative to coverage for chronic illness |
Mark C. Montigny |
|
20 |
S.712 |
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices |
Mark C. Montigny |
|
21 |
S.715 |
An Act relative to pharmaceutical price transparency and cost sharing |
Patrick M. O'Connor |
|
22 |
S.721 |
An Act relative to mandatory prescription drug coverage |
Bruce E. Tarr |
|
23 |
S.728 |
An Act providing affordable access to generic medicines |
Dean A. Tran |
|
24 |
S.733 |
An Act relative to consumer protection for prescription drug purchases |
James T. Welch |